REPRODUCTIVE MOOD DISORDERS: From Menarche to Menopause The role of stress and steroid hormone sensitivity by Girdler, Susan
Susan S. Girdler, Ph.D., FABMR  
Department of Psychiatry 
University of North Carolina at Chapel Hill
NIH: RO1s-MH051246; MH087619; MH099076; and MH108690; CTRC UL1RR025747
 
 
 
REPRODUCTIVE MOOD DISORDERS: 
From Menarche to Menopause  
 
The role of stress and steroid hormone sensitivity 
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Gender Differences in Lifetime Rate  
for Major Depression 
Incidence of Major Depression  
in Males and Females
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Start of gender 
differentiation
Incidence of Depression in Women  
Across the Lifecycle 
Stahl, S.M., (2000). Essential Psychopharmacology, (2).  
Wise, D. D., Felker, A., & Stahl, S. M. (2008).CNS Spectr, 13(8).
The Risk of Depressive Symptoms in Women  
Associated with Reproductive Events
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Objectives
● Clinical Phenomenology of  
Reproductive Mood Disorders (RMDs):  
➢ Premenstrual Dysphoric Disorder 
➢ Postpartum Depression 
➢ Perimenopausal Depression  
● Vulnerability to ‘normal’ hormonal CHANGE  as 
etiologically relevant  
    – a hormone sensitive “phenotype” 
●  STRESS and stress response dysregulation in the 
pathogenesis of RMDs
Hypothalamus: 
        CRH 
Locus Coeruleus: 
                   NE
pituitary
cortisol
ACTH
adrenaline
Sympathetic 
ganglion
NE & 
neuropeptides
Hypothalamic-pituitary-
adrenal (HPA) axis 
Regulates: 
•Metabolism of glucose 
•Immune activation 
Sympathetic Nervous 
System 
           or  
“Flight or Fight” 
Regulates:  
•Heart rate 
•Blood Pressure
STRESS AXES


WHEN PHYSIOLOGIC RESPONSES TO 
STRESS ARE IN EXCESS OF OUR 
METABOLIC NEEDS
How Stress Gets “Under the Skin”  
to Promote Illness
PUBERTY!

Adolescent sex differences in the 
nature of stressors
*<0.01, **0<.001 
Hankin, B. L., Mermelstein, R., & Roesch, L. (2007). Child development, 78(1), 279-295.
**
 
Hankin, B. L., Mermelstein, R., & Roesch, L. (2007) Child development, 78(1), 279-295 
Adolescent girls show greater depressive 
symptoms under stress than do boys 
Girls’ depressive symptoms by 
grade and pubertal timing 
Adapted from: Ge, X., Conger, R.D., & Elder, G.R. (2001). Developmental Psychology, 37(3), 404-417. 
Pubertal timing and peer stress predict 
longitudinal depression in adolescent girls
Adapted from: Conley, C. S., & Rudolph, K. D. (2009). Development and psychopathology, 21(02), 593-620.
Child abuse and early timing of 
menarche (< 11 yrs)
*
*p<0.01 
*
Boynton-Jarrett et al. (2013). The Journal of adolescent health: official publication of the Society for 
Adolescent Medicine, 52(2), 241.
Report of physical and/or sexual abuse in 
childhood (< 12 yrs) 
(N=67,658) 
Boynton-Jarrett et al. (2013). The Journal of adolescent health: official publication of the Society for 
Adolescent Medicine, 52(2), 241.
Current 
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Depression 
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Biobehavioral model of female 
adolescent depression
Intervene
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Frank, RT.  Archives of Neurology & Psychiatry, 26, 1931
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Estrogen and Progesterone Beneficially 
Modulate Systems Implicated in Depression 
and Anxiety
● Regulates the synthesis, metabolism, and receptor concentration of 
neurotransmitters implicated in depression (i.e., serotonin, dopamine, 
norepinephrine) (Rubinow et al., Biol Psychiatry 44, 1998; Malyala et al., Steroids 70, 2005). 
● Physiologic responses to stress, including the Hypothalamic-Pituitary-
Adrenal (HPA) axis  (Peiffer et al, Endocrinology 129, 1991).     
● Modulates neuroprotection in brain (Sato et al., Brain Res 1150, 2007; Scharfman et al., 
Headache 48, 2008;  McEwen BS Endocr Rev 20, 1999) 
● Prevents or counteracts the pro-inflammatory processes described as 
contributing to depression (Leonard, BE.  Prog Neuropsychopharmacol Biol Psychiatry 15, 
2001)
FEMALE REPRODUCTIVE HORMONAL 
FLUX ACROSS THE MENSTRUAL CYCLE
Luteinizing hormone (LH)
Follicle-stimulating 
hormone (FSH)
  Estradiol Progesterone
Menses Menses
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     0 days                        14 days                 28 days 
                                                  
                                                             Ovulation
Duration of immobility during the tail 
suspension test is measure of ‘depression’ in 
female mice
Female mice stressed during puberty (6 weeks) show a 
depressogenic effect when exposed to estrogen in adulthood 
TIME of STRESS EXPOSURE
Blaustein et al., Hormones and Behavior, Volume 64, Issue 2, 2013.
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Time (latency) to bury marbles is an index 
of anxiety in female mice
Female mice stressed during puberty (6 weeks) fail to experience the 
anxiolytic effect of estrogen and progesterone in adulthood 
Blaustein et al., Hormones and Behavior, Volume 64, Issue 2, 2013.
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Biological Systems Implicated in the 
Pathogenesis of PMDD
● Differential sensitivity to mood effects of gonadal steroid 
fluctuations  
● Serotonergic dysfunction 
● Adrenergic dysregulation 
● GABAergic neurosteroids 
● Thyroid hormones
PMDD
 as a S
tress -
 Relat
ed Dis
order
● Clinically distinct subgroups of PMDD 
women for whom historical factors provide 
a context of vulnerability for stress response 
dysregulation and perhaps for the 
development of the disorder
Schmidt et al., (1998). N Engl J Med: 338(4).
Hormone Sensitive Phenotype in PMDD
Efficacy of GnRH-A in the Sxs of PMDD          
(Weekly Means + SEM)
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Eisenlohr-Moul et al., Psychoneuroendocrinology 67 (2016) 142–152 
Relationship between changing estrogen and progesterone levels 
and symptom severity in 66 women with PMDD
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Abuse Interview 
(Leserman et al., Psychosom Med 1996;58:4-15)
● Sexual Abuse (SA): 
 Adult: Clear threat of harm or force 
   Child (<14 yrs): threat or force not required 
if implied by age differential 
2 Types: 1) forced sexual touching 
               2) intercourse (rape)
Abuse Interview (cont.)
● Physical Abuse (PA): 
     2 Types: 1) beat, hit or kicked 
                    2) life threat (intent to kill or    
                        seriously injure) 
  Only counted if the incident(s) occurred 
separately from any SA incident
01 0
2 0
3 0
4 0
5 0
PMDD 
(n=129)
Controls 
(n=70)
Greater Rates of  Sexual and Physical Abuse in PMDD 
Sexual Physical
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*p<.05
*p<.05
Girdler et al., Psychosom Med, 65, 2003; Girdler et al., Health Psychol, 26(2), 2007; Fleischman et al., Health Psychol, 2013 
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Histories of Abuse predict a hormone sensitive phenotype  
in women with PMDD
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Eisenlohr-Moul et al., Psychoneuroendocrinology 67 (2016) 142–152 
Childhood Sexual Abuse predicts Migraine with Aura (ICHD-II criteria) in 
Women with PMDD
      *Fisher exact test, p = 0.019. 
Bunevicius et al., (2013) Journal of Women’s Health, 22(10).
*
*
N = 174
*Adapted from: Bunevicius et al., (2005). Biol Psychol
PMDD Women PMDD Women Non-PMDD
Adapted from: Girdler et al., (2007). Health Psychol
No Abuse Abuse
* Abuse > No Abuse in PMDD only, p < .05. 
PMDD Women with a History of Abuse Have  
Greater Sympathetic Responses to Mental Stress
The Hypothalamic-Pituitary 
Thyroid Axis
Hypothalamus
Ant. Pituitary
TRH
TSH
Thyroid Gland
T4 T3
T3
HPT-Axis Facts
● T3 is 4x more biologically active than T4 
● Tissues use T3 in preference to T4 
● Like other tissues, brain makes T3 from T4 
● T3 and T4 penetrate the BBB 
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A History of Sexual Abuse (SA) is associated with 
Elevated TSH concentrations
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A History of Sexual Abuse (SA) differentially Impacts 
T3 concentrations in PMDD vs. non-PMDD women
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Bunevicius et al., Psychosom Med, 74(8) : 2012 *PMDD x SA, p<.05
*
*
●A History of Abuse May Identify a Clinically Distinct Subgroup of Women with PMDD 
Conclusions
Incidence Threshold 
PMDD versus no PMDD
Baseline Predictors OR 95% CI
Age at final follow-up 0.8 0.7 to 0.9
Subthreshold PMDD 11.0 4.7 to 25.9
Any qualifying trauma 4.2 1.2 to 12.0
Diagnosis of PTSD at baseline 0.7 0.1 to 2.8
Low self-competence 1.1 0.7 to 1.8
No. of negative life events 0.9 0.7 to 1.3
Increased daily hassles 1.6 1.1 to 2.3
Substance use disorder 0.4 0.1 to 1.6
Nicotine dependence 1.7 0.6 to 4.5
Any anxiety disorder 2.5 1.1 to 5.5
Any mood disorder 1.1 0.4 to 3.2
Any somatoform disorder/syndrome 0.8 0.3 to 2.1
Any eating disorder 2.2 0.8 to 6.9
Predictors of New-Onset (Incident) PMDD in a Sample of 1251 Women
Perkonigg et al. (2004).  J Clin Psychiatry
48
Postpartum Depression
➢ COMMON 
• 10-15% prevalence 
• 4 million women give birth annually in U.S.; ½ million with PPD 
•  Most common, unrecognized complication of perinatal period 
➢ MORBIDITY AND MORTALITY 
•  Devastating consequences for patient and family 
● Impaired bonding between mother and infant 
● Leading cause of maternal mortality in the postpartum 
period  
➢ PREDICTORS 
• History of depression 
• Depression or anxiety during pregnancy 
• Stressful life events 
• Poor social support 
Herrick, H. W. (2000).The Effect of Stressful Life Events on Postpartum Depression Results from the 1997-1998 North 
Carolina Pregnancy Risk Assessment Monitoring System (PRAMS)
Percentage of Mothers with Postpartum Depression by  
Total Number of Stressful Life Events
TSST
Greater HPA Axis  Response to Stress During Pregnancy 
 Predicts Post Partum Depression within One Month of Delivery
STRESS
Rates of Affective Disorders for Mothers at 
6 weeks Postpartum
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Matthey, S., et al., (2003). Journal of affective disorders, 74(2).
Reproductive Steroid Hormone Profile in Pregnancy and the 
Immediate Postpartum Period 
Euthymic Women with a History of PPD  
vs. No History of PPD
 L Leuprolide acetate (3.75 mg/month) 
 E2 Micronized estradiol (10mg/day)  
 P4 Micronized progesterone   
(target level = 50 ng/ml; 400-900 mg/day)
Baseline
 
Addback Withdrawal Follow Up
Months
 1  2     3         4   5  12 weeks
 L  L    L        L            L 
  
No hormone 
manipulation
  E2       E2 
  P4    P4 
Bloch, M., et al., (2000).  American Journal of Psychiatry, 157(6).
Women with a History of PPD are Differentially Sensitive to  
Hormone Withdrawal 
Effects of Hormones on Mood in women with a 
history of Postpartum Depression
Hx PPD n = 12  
Control n = 15
Schiller, C. et al., presented at the 2016 meeting of the Society of Biological Psychiatry 
The Menopause Transition  
Depression in the Menopause Transition 
● The risk of first-onset 
depression increases 2 fold 
● A history of depression 
increases risk 4 fold 
– Major Depression: 9-17%1,2 
– Clinically significant depressive 
symptoms:        24-33%1,3
1. Cohen et al. (2006), JAMA Psychiatry, 63: 385-390. 2. Bromberger et al. (2011), Psychological Med, 41, 1879-1888. 3. 
Bromberger et al., (2007), J Affect Disord, 103, 267-272.
Hormone sensitive depressive phenotype in 
women with a past history of  
perimenopausal depression
Schmidt eta l., JAMA Psychiatry, 2015 Jul;72(7):714-26

Endocrine Changes Around Menopause
Hormone Fluctuations in the  
Late Menopause Transition
O’Connor et al. (2009). Menopause, 16(6).
Pr
og
es
te
ro
ne
E
st
ra
di
ol
FS
H
Freeman, E. W. et al. (2006) Arch Gen Psychiatry 2006;63.
Hormone Odds Ratio CI P Value
Estradiol (pg/
ml)
    Mean     1.06 (0.63 – 1.78) .83
    Variability 
    (SD) 1.36 (1.02 – 1.80) .03
FSH  
(pg/ml)
     Mean 4.58 (2.03 – 10.35)
.001
     Variability 
      (SD) 2.09 (1.70 – 3.41) .001
Depression During the Menopause Transition: 
 Association with Mean Hormone Levels and Hormone  Variability 
Perimenopausal Estrogen Replacement Therapy Study 
Funded by the National Institutes of Health:  
NIH RO1 MH087619 
 Principal Investigators:  
Susan Girdler, Ph.D. and David Rubinow, M.D. 
Center for Women’s Mood Disorders 
University of North Carolina at Chapel Hill
Cohort: Medically  healthy, non-depressed 
women, 45 – 60 years of age in the menopause 
transition (STRAW -1 or -2)
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Mid-Life Women Are at High Risk for 
Very Stressful Life Events 
(past 6 months)
N=236Gordon, et al., Menopause, Volume 23(3), 2016
Mid-life Women with both  high levels of stress and high estrogen 
variability DEVELOP depression in the menopause transition
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Menopause Transition  
(14 Months)
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(6 months)
Gordon, et al., Menopause, Volume 23(3), 2016
The Trier Social Stress Test
Minutes
Women in the Late Menopause Transition (more erratic hormones) Show Greater 
Cortisol Reactivity to Stress  
*
* P<.01
Gordon, et al., Menopause, Volume 23(3), 2016
Greater estradiol variability over 8 months predicts more 
negative emotional responses to psychosocial stress
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High rejection sensitivity in combination with stressful life events 
predicts the development of depression symptoms over 14 months
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Biobehavioral Model of Reproductive Mood Disorders  
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